AXGN saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 73 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AXGN's RSI Oscillator exited the oversold zone, 18 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on October 20, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Following a +4.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in 271 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
AXGN moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
AXGN broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AXGN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.705) is normal, around the industry mean (3.837). P/E Ratio (-56.746) is within average values for comparable stocks, (2.078). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). AXGN has a moderately high Dividend Yield (0.105) as compared to the industry average of (0.010). P/S Ratio (8.961) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ICUI's Aroon Indicator triggered a bullish signal on October 26, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator showed a similar pattern. In 153 of the 204 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 75%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Indicator exited the oversold zone, 22 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 38 of 51 cases over the following month. The odds of a continued upward trend are 75%.
Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 59 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICUI as a result. In 68 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
ICUI moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
ICUI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.897) is normal, around the industry mean (4.942). ICUI has a moderately high P/E Ratio (136.000) as compared to the industry average of (37.224). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
AXGN | ICUI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 38 | 100 | |
SMR RATING 1..100 | 95 | 89 | |
PRICE GROWTH RATING 1..100 | 46 | 41 | |
P/E GROWTH RATING 1..100 | 35 | 97 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AXGN's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for ICUI (88). This means that AXGN’s stock grew significantly faster than ICUI’s over the last 12 months.
AXGN's Profit vs Risk Rating (38) in the Medical Specialties industry is somewhat better than the same rating for ICUI (100). This means that AXGN’s stock grew somewhat faster than ICUI’s over the last 12 months.
ICUI's SMR Rating (89) in the Medical Specialties industry is in the same range as AXGN (95). This means that ICUI’s stock grew similarly to AXGN’s over the last 12 months.
ICUI's Price Growth Rating (41) in the Medical Specialties industry is in the same range as AXGN (46). This means that ICUI’s stock grew similarly to AXGN’s over the last 12 months.
AXGN's P/E Growth Rating (35) in the Medical Specialties industry is somewhat better than the same rating for ICUI (97). This means that AXGN’s stock grew somewhat faster than ICUI’s over the last 12 months.
| AXGN | ICUI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 7 days ago 69% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 70% | 3 days ago 75% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 74% |
| Advances ODDS (%) | 6 days ago 82% | 17 days ago 68% |
| Declines ODDS (%) | 1 day ago 82% | 1 day ago 71% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 70% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 75% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXGN’s FA Score shows that 1 FA rating(s) are green while ICUI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXGN’s TA Score shows that 4 TA indicator(s) are bullish while ICUI’s TA Score has 4 bullish TA indicator(s).
AXGN (@Medical/Nursing Services) experienced а +3.57% price change this week, while ICUI (@Pharmaceuticals: Other) price change was +1.32% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was -8.28%, and the average quarterly price growth was -7.48%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.35%. For the same industry, the average monthly price growth was -3.01%, and the average quarterly price growth was +10.29%.
AXGN is expected to report earnings on Oct 28, 2026.
ICUI is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+0.35% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with XRAY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then XRAY could also see price increases.
| Ticker / NAME | Correlation To AXGN | 1D Price Change % | ||
|---|---|---|---|---|
| AXGN | 100% | -1.47% | ||
| XRAY - AXGN | 36% Loosely correlated | +1.41% | ||
| ITGR - AXGN | 31% Poorly correlated | +0.17% | ||
| CLPT - AXGN | 31% Poorly correlated | +7.19% | ||
| GMED - AXGN | 31% Poorly correlated | -1.14% | ||
| ICUI - AXGN | 30% Poorly correlated | -1.66% | ||
More | ||||
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | -1.66% | ||
| CLPT - ICUI | 57% Loosely correlated | +7.19% | ||
| ALGN - ICUI | 51% Loosely correlated | -0.20% | ||
| MMSI - ICUI | 50% Loosely correlated | -0.71% | ||
| A - ICUI | 50% Loosely correlated | +0.87% | ||
| BLCO - ICUI | 49% Loosely correlated | +0.23% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BITX | 18.00 | 0.36 | +2.04% |
| Volatility Shares 2x Bitcoin ETF (BITX) | |||
| GSC | 63.27 | 0.68 | +1.09% |
| Goldman Sachs Small Cap Equity ETF (GSC) | |||
| ENHI | 26.61 | 0.17 | +0.64% |
| iShares Enhanced International Active ETF (ENHI) | |||
| BRIB | 24.46 | 0.03 | +0.12% |
| FIS Bright Portfolios Core Bond ETF (BRIB) | |||
| BBYY | 8.19 | 0.01 | +0.07% |
| GraniteShares YieldBOOST BABA ETF (BBYY) | |||